Status:
UNKNOWN
Quality of Life and Sexual Function of the Novasure Endometrial Ablation in Menorrhagia
Lead Sponsor:
Shu-Qin Chen
Conditions:
Quality of Life
Sexual Activity
Eligibility:
FEMALE
25-50 years
Brief Summary
The aim of this study is to investigate the influence on the quality of life and sexual function before, 6 month and one year after Novasure Endometrial Ablation in the treatment of Menorrhagia.
Detailed Description
patients diagnosed menorrhagia scheduled for Novasure Endometrial Ablation because of menorrhagia between november, 2012 and november, 2014 are enrolled to this study. patients are asked to complete ...
Eligibility Criteria
Inclusion
- clinical diagnosis of menorrhagia
- family complete
- normal endometrial pathology
- had not been referred specifically for surgery
- with normal uterine cavity
Exclusion
- pregnancy or demand to preserve fertility
- acute reproductive tract inflammation or urinary tract inflammation
- pathology demonstrate endometrial cancer or precancerous change
- acute pelvic inflammation
- intrauterine device(IUD) in uterus
- depth of uterine cavity less than 4cm or more than 10cm
- pathologic myometrium( such as history of Hysteromyomectomy or classical cesarean section)
Key Trial Info
Start Date :
November 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01910584
Start Date
November 1 2012
End Date
November 1 2015
Last Update
July 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Sun yat-sen University
Guangzhou, Guangdong, China, 510080